SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902219-20-000376
Filing Date
2020-04-09
Accepted
2020-04-09 08:53:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 36017
  Complete submission text file 0000902219-20-000376.txt   37809
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89517 | Film No.: 20783268
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences